Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 7,500 shares at $176.47 ($1.3M) on 2018-03-09, disclosed to the SEC on 2018-03-09.
Open-market sale of $1.3M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $174.88 | 3,500 | $612K | 46.4% |
| 2 | $176.47 | 4,000 | $706K | 53.6% |
| Total | $175.73 avg | 7,500 | $1.3M | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |